Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity

Documenti analoghi

• Discovery of the First N-Hydroxycinnamamide-Based Histone Deacetylase 1/3 Dual Inhibitors with Potent Oral Antitumor Activity
  di: Li, Xiaoyang, et al.
  Pubblicazione: (2014)
• Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
  di: Zhao, Na, et al.
  Pubblicazione: (2020)
• Novel Histone Deacetylase Inhibitors with Enhanced Enzymatic Inhibition Effects and Potent in vitro and in vivo Anti-tumor Activities
  di: Zhang, Lei, et al.
  Pubblicazione: (2013)
• Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with an Indole-Containing Cap Group
  di: Zhang, Yingjie, et al.
  Pubblicazione: (2013)
• Development of hydroxamate-based histone deacetylase inhibitors of bis-substituted aromatic amides with antitumor activities
  di: Ge, Di, et al.
  Pubblicazione: (2019)